Inflammation is emerging as a common driver across cardiology, oncology, neurology and rheumatology, reshaping how researchers approach major diseases. BioAge L

Inflammation is emerging as a common driver across cardiology, oncology, neurology and rheumatology, reshaping how researchers approach major diseases. BioAge Labs is advancing that thesis with a Phase 2 obesity/cardiovascular trial and a planned eye study.